Thailand – Updates to Trademark E-Filing System

The Department of Intellectual Property (DIP) has rolled out changes to its Trademark E-Filing System, as of 29 September 2025. These updates address common filing issues, enhance system integration, and strengthen user authentication. Trademark Image Uploads To prevent errors in official forms, the system will no longer accept trademark images uploaded with transparent backgrounds and […]

India’s 2025 CRI Guidelines: A New Era for Software and AI Patent Examination

India has ushered in a transformative phase in its intellectual property regime with the release of the 2025 Guidelines for the Examination of Computer-Related Inventions (CRIs). Issued by the Office of the Controller General of Patents, Designs & Trademarks (CGPDTM) on July 29, 2025, these guidelines mark a significant evolution in how software and artificial […]

Calcutta High Court Overturns Patent Rejection: Clarifies Standards for Morality and Public Health Exclusions

The Calcutta High Court’s judgment, in ITC Limited v. The Controller General of Patents Designs and Trademarks (IPDPTA/13/2024) marked a crucial development in Indian patent law by overturning the rejection of ITC’s patent application (No. 685/KOL/2015) for “a device and method to generate and deliver a nicotine aerosol”. The case centered on Section 3(b) of […]

INDIA- JUDICIAL CLARIFICATION ON SECTION 3(e) VS SECTION 3(d)- ORAMED LTD. vs THE CONTROLLER GENERAL OF PATENTS AND DESIGNS

In a recent ruling concerning pharmaceutical patents, the Calcutta High Court set aside a decision by the Controller of Patents for erroneously conflating the distinct legal standards for patentability of an invention. The judgment underscores ongoing concerns regarding inconsistencies in the examination of pharmaceutical composition claims, particularly where the statutory criteria are misapplied. Facts: The […]

Case summary of Symphony Holdings Limited v Skins IP Limited [2025] SGIPOS 3

I. Background Symphony Holdings Limited v. Skins IP Limited [2025] SGIPOS 3 concerned an opposition by Symphony Holdings Limited (the “Opponent”) against an application by Skins IP Limited (the “Applicant”) to register the following word trade mark, “SKINS”, (the “Subject Mark”) in Singapore. The Opponent, a Hong Kong-based sports-branding company, opposed the application based on […]

Delhi High Court rejects Salmonella patent despite approval by USPTO and EPO

In Regents of the University of California (the ‘Appellant’) vs Controller of Patents and Designs (the ‘Respondent’) [C.A.(COMM.IPD-PAT) 481/2022], the Delhi High Court upheld the rejection of a patent application for genetically modified salmonella vaccine due to insufficient disclosure and overly broad claims, non-patentable subject matter, and failure to deposit recombinant microorganism as required under […]

EP patent validation in Laos

Following the Validation Agreement signed between the Laos Department of Intellectual Property (‘DIP’) and the European Patent Office (‘EPO’), European patent holders can now extend their patent protection to Laos without the need for a separate national application, effective 1 April 2025. This makes Laos the sixth country worldwide, and the second in Southeast Asia […]

Exploring the New Patent Playbook: Establishing a prima facie case before the issuance of a Notice for Pre-Grant Oppositions

Introduction In India Patent Application No. 202417006578, the Assistant Controller of Patents & Designs, issued an order in the context of a Pre-grant Opposition (‘PGO’) against Pharmazz Inc.’s said patent application. This decision is particularly notable as it represents the first application of a new rule requiring the establishment of a prima facie case before […]